Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Medical and Pediatric Oncology|May 10, 2001
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group StudyE Rudnick, Y Khakoo, N L Antunes, et al.Cancer|April 5, 2008
Heart failure associated with sunitinib malate: a multitargeted receptor tyrosine kinase inhibitorAarif Y Khakoo, Christos M Kassiotis, Nizar Tannir, et al.Cancer|November 4, 2009
Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylateJonathan C Trent, Shalin S Patel, Jianhu Zhang, et al.Journal of Molecular and Cellular Cardiology|September 15, 2010
Mesenchymal stem cells stimulate protective genetic reprogramming of injured cardiac ventricular myocytesTerry B Rogers, Shibani Pati, Shirley Gaa, et al.Nature Reviews. Clinical Oncology|July 4, 2012
Reducing the toxicity of cancer therapy: recognizing needs, taking actionCharles S Cleeland, Jeff D Allen, Samantha A Roberts, et al.American Journal of Physiology. Heart and Circulatory Physiology|July 7, 2018
Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodelingBrendan P Purcell, Shayne C Barlow, Paige E Perreault, et al.American Journal of Physiology. Heart and Circulatory Physiology|July 30, 2017
Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and functionShayne C Barlow, Heather Doviak, Julia Jacobs, et al.Circulation|October 29, 2020
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection FractionVirginia S Hahn, Hildur Knutsdottir, Xin Luo, et al.Stem Cells and Development|May 8, 2010
Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signalingShibani Pati, Aarif Y Khakoo, Jing Zhao, et al.The Journal of Pharmacology and Experimental Therapeutics|September 22, 2020
Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-Myocardial Infarction RemodelingDavid C Lobb, Heather Doviak, Gregory L Brower, et al.Pageof 5